Another nail in the AML coffin

Affiliations

Free article

Comment

Camille N Abboud. Blood. 2009.

Free article

. 2009 Jun 11;113(24):6045-6.

doi: 10.1182/blood-2009-03-189803.

No abstract available

Comment on

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
Zeng Z, Shi YX, Samudio IJ, Wang RY, Ling X, Frolova O, Levis M, Rubin JB, Negrin RR, Estey EH, Konoplev S, Andreeff M, Konopleva M. Zeng Z, et al. Blood. 2009 Jun 11;113(24):6215-24. doi: 10.1182/blood-2008-05-158311. Epub 2008 Oct 27. Blood. 2009. PMID: 18955566 Free PMC article.
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
Nervi B, Ramirez P, Rettig MP, Uy GL, Holt MS, Ritchey JK, Prior JL, Piwnica-Worms D, Bridger G, Ley TJ, DiPersio JF. Nervi B, et al. Blood. 2009 Jun 11;113(24):6206-14. doi: 10.1182/blood-2008-06-162123. Epub 2008 Dec 2. Blood. 2009. PMID: 19050309 Free PMC article.